GlassScriptPhysician profile
Raymond L Gilbert
NPI 1831184209
$8,553.00
in general payments reported to CMS, 2019-2025
41 companies · $633 in 2025
The $633 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,411 · 2020: $1,261 · 2021: $1,508 · 2022: $1,749 · 2023: $1,129 · 2024: $863 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,624 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,624.23 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,831.28 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $980.66 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $780.86 | 2019-2025 | Repatha, Otezla, Repatha |
| Abbvie INC. | $603.80 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $592.03 | 2019-2025 | Jardiance, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $387.42 | 2021-2023 | |
| Pfizer INC. | $345.12 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $280.18 | 2019-2024 | Xifaxan |
| Glaxosmithkline, LLC. | $261.55 | 2020-2025 | Trelegy Ellipta, Shingrix |
| Amarin Pharma, INC. | $231.28 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $231.03 | 2019-2022 | |
| Lilly USA, LLC | $229.42 | 2019-2023 | Mounjaro, Trulicity |
| Kowa Pharmaceuticals America, INC. | $191.70 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $153.61 | 2019-2022 | |
| Astellas Pharma US INC | $138.56 | 2021-2024 | Veozah, Myrbetriq |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.